LIVE from #AIDS2024 in Munich 🎥 Access to LIFESAVING point-of-care CD4 tests that measure #HIV's impact on the immune system is under threat due to limited supply. We need continued manufacturing of accurate & affordable CD4 tests to SAVE MORE LIVES!

📢#AIDS2024 Daily Highlights: Exploring Grassroots Interventions to Tackle Misinformation, Designing AI for inclusive healthcare is crucial to address the digital divide, Citizen Science JIAS Special Edition & more! Read here 👉🏽bit.ly/aids2024-25-ju…

#AIDS2024 #HIV #Dolutregavir ViiV Healthcare #DropTheCase

Con camisetas y convicción, pedimos a GSK/ViiV que dejen de bloquear el acceso al Dolutegravir en Colombia. ¡Es un derecho humano! 🗣️🇨🇴 #Dolutegravir #AIDS2024 #DropTheCase #GlaxoViiVAbandonenElCaso #DTGenColombiaYa

Thank you to everyone that passed by our ArTivism booth in #AIDS2024 #GlobalVillage . Between a printed graffiti background, audiovisual material with the work of MMA's consortium and an epic collection of activists t-shirts, this booth was not only a walk down the memory lane of

On July 24th, hundreds of treatment advocates at #AIDS2024 in #Munich protested with #DropTheCase slogans to denounce GSK and ViiV Healthcare 's decision to challenge compulsory license issued by #Colombia. This dangerous move prevents thousands of people living with #HIV from

Lenacapavir, the twice-yearly #HIV prevention injections that were 100% effective in recent trials, could “reverse the epidemic if made available in the countries with the highest rate of new infections.” - @bygrave_helen, our Chronic Disease Advisor👇 apnews.com/article/africa…

To achieve 10-10-10 targets by 2025: 🚫Advocate for decriminalising drug use, sex work & same-sex relationships. 🤝Build alliances with women's & human rights groups to push anti-discrimination laws. 📢Empower communities to voice & influence decisions impacting them.

#Mpox #livesnotprofit

#Mpox #COVID19

Read about collaborative dialogues convened by KELIN with support from Aidsfonds International focusing on HIV prevention tools and IP challenges affected access to medicines. Mercy Pesa Okania Read prevention study findings here: kelinkenya.org/wp-content/upl… kelinkenya.org/collaborative-…

#lenacapavir #HIV Gilead Sciences

How can we turn breakthroughs in long-acting #HIV prevention & therapy into real-world impact? Despite promising advancements, urgent coordination is needed to ensure access in low- & middle-income countries where HIV is most prevalent. Read more 👉🏽bit.ly/lancet-hiv

#HIV #TB #Kenya KELIN

🚨 A research paper has been published, demonstrating how #lenacapavir could be mass-produced for $40 per year to meet increased demand. The paper was prepared with the support of the ITPC Global Make Medicines Affordable campaign. Read more: ⚡️💊👇🏿 #HIV academic.oup.com/jac/advance-ar…

There have been over a million new cases of #HIV each year.  #Lenacapavir, a long-acting antiretroviral, could change the trajectory of this global epidemic, but Gilead Sciences' patent monopoly will keep it unaffordable for many in urgent need. ⚡️🚨👇🏿 tinyurl.com/mvw59wb2

“Without a steady supply of affordable #Lenacapavir from India, ending #AIDS will remain an elusive goal. Decisions made by #Indian patent offices are a matter of life or death for people living with #HIV/AIDS worldwide.” Read more on our website: 🚨⚡️👇🏿 tinyurl.com/2dh78kw8

#Lenacapavir #HIV #PrEP #LivesNotProfit

We’re at a pivotal moment in history as we approach the United Nations #SummitoftheFuture on September 22-23. The Summit holds great promise for building a better present and safeguarding the future. However, a key challenge remains at risk of being overlooked: Health.

We need a pact for the #future with lower prices through #generic competition, omellouk , lead of the intellectual property and access to medicines program #MMA at ITPC Global